Under the agreement, bioAffinity’s sputum analysis will be combined with Pictor’s proteomic platform to analyse inflammation.
Mepolizumab is a monoclonal antibody that targets interleukin-5, a key cytokine in eosinophilic inflammation. The MATINEE ...
A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...
The case accuses OpenAI of practicing medicine without a license and failing to safeguard users seeking health advice.
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2026 ...
The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion ...
BLVR has shown potential for restoring lung function and improving quality of life among individuals with chronic obstructive pulmonary disease (COPD), who have few other options for treatment, said ...
Cognitive impairment, manual dexterity, and suboptimal peak inspiratory flow are associated with inadequate inhaler technique and poor outcomes in patients with chronic obstructive pulmonary disease ...
Complementary MESA analyses validate AI-derived chamber volumetry from non-gated, non-contrast CT for heart failure and ...
Canadian wildfire smoke is expected to continue blanketing Massachusetts on Thursday, state officials reported, with air ...
The City of Flint is launching a new Division of Health Strategies and Advancements, aimed at addressing health disparities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results